A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Akebia Therapeutics Inc’s current trading price is -16.15% away from its 52-week high, while its distance from the 52-week low is 219.63%. The stock’s price range for this time frame has been between $1.07 and $4.08. The trading volume of the company’s shares in the Healthcare reached around 5.82 million for the day, which was evidently higher than the average daily volume of 4.96 million over the last three months.
Akebia Therapeutics Inc (AKBA) has a current stock price of $3.42. During the previous trading session, the stock witnessed a notable rise, reaching a high of $10.0 after opening at $3.42. The stock’s low for the day was $6.0, and it eventually closed at $3.01.
The market performance of Akebia Therapeutics Inc has been somewhat stable.
How Financial Performance Impacts Market Capitalization
Akebia Therapeutics Inc (AKBA) has experienced a quarterly rise of 30.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 906.80M and boasts a workforce of 181 employees.
Decoding Analysts’ Ratings for Akebia Therapeutics Inc
As of right now, 3 analysts are rating Akebia Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
How AKBA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AKBA stands at 7.21. Similarly, the long-term debt-to-equity ratio is also 6.10.
AKBA Stock Stochastic Average
The raw stochastic average for Akebia Therapeutics Inc over the last 50 days is presently at 5.14%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 9.76%. Further, the company’s Stochastic %K and %D values for the last 20 days were 3.55% and 2.42%, respectively.
AKBA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 178.05% this year. Over the last six months, there has been a weaker performance of 58.33%. The price of AKBA leaped by -14.07% during the last 30 days period. For the last 5-days stocks have slided -8.06%.
